SCHEMBL3781473

SCHEMBL3781473

CC(=O)SOc1cc(N)ccc1-c1cccc(N)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB4A P04350 5/20 0.40
TUBB P07437 5/20 0.40
TUBA3C P0DPH7 5/20 0.40
TUBA1B P68363 5/20 0.40
TUBA4A P68366 5/20 0.40
TUBB4B P68371 5/20 0.40
TUBB3 Q13509 5/20 0.40
TUBB2A Q13885 5/20 0.40
TUBB8 Q3ZCM7 5/20 0.40
TUBA3E Q6PEY2 5/20 0.40
TUBA1A Q71U36 5/20 0.40
TUBA1C Q9BQE3 5/20 0.40
TUBB6 Q9BUF5 5/20 0.40
TUBB2B Q9BVA1 5/20 0.40
TUBB1 Q9H4B7 5/20 0.40
MAOA P21397 2/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.38
BRD4 O60885 1/20 0.38
ALDH1A1 P00352 3/20 0.37
MCL1 Q07820 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3786324 0.90 PTGDR2 (0.48) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL3792023 0.88 PTGDR2 (0.47) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL3789776 0.88 ADRA2A (0.43) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL3791104 0.86 ALDH1A1 (0.39) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL3785607 0.85 MAP4K4 (0.40) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL3784462 0.82 BACE1 (0.43) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL3785345 0.80 BRD4 (0.36) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL3793489 0.79 ALDH1A1 (0.38) PTGDR2BRD4ALDH1A1MAPTKDM4E
SCHEMBL3785270 0.79 MCL1 (0.43) MAOAALDH1A1MCL1MAPTKDM4E
SCHEMBL3792743 0.79 MCL1 (0.43) MAOAALDH1A1MCL1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 TUBB4A 2007/4885TUBB 1532/4885TUBA3C 2185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.